Conversation with Raphael Mechoulam.

@article{Mechoulam2007ConversationWR,
  title={Conversation with Raphael Mechoulam.},
  author={Raphael Mechoulam},
  journal={Addiction},
  year={2007},
  volume={102 6},
  pages={
          887-93
        }
}
In this occasional series we record the views and personal experience of people who have specially contributed to the evolution of ideas in the Journal’s field of interest. Entering what was, at the start, a neglected field, Raphael Mechoulam went on to pursue, over the next 40 years, a highly productive career in cannabis research. This interview charts a sequence of discoveries and reveals something of the dedication and intellectual daring which has characterized the enterprise throughout. 
BETA
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 17 REFERENCES

N-Arachidonoyl 1-serine, a novel endocannabinoid-like brain constituent with vasodilatory properties

  • G. Milman, Y. Maor, S. Abu-Lafi, M. Horowitz, R. Gallily, S Batkai
  • Proc Natl Acad Sci USA
  • 2006
1 Excerpt

Evidence that the plant cannabinoid delta-9-cannabivarin is a cannabinoid CB1 and CB2 receptor agonist

  • A. Thomas, L A.Stevenson, K N.Wease, M R.Pryce, G. Baillie, R ARoss
  • Br J Pharmacol
  • 2005
1 Excerpt

The non-psychoactive cannabis-constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

  • A M.Malfait, R. Gallily, P F.Sumariwalla, A S.Malik, E. Andreakos, R Mechoulam
  • Proc Natl Acad Sci USA
  • 2000
1 Excerpt

Similar Papers

Loading similar papers…